Wearables Made Sleep Measurable. The Next Step Is Making It Treatable.

Sleep has quietly become one of the most measured parts of modern health. Millions of people now wake up to scores from Apple Watch, Oura, Whoop, Garmin, and other devices telling them how long they slept, how often they woke up, how their heart rate changed, and whether their recovery is improving. 

This is a major shift. Sleep used to be invisible. Today, it is becoming a daily health signal. 

But measurement has exposed a new problem: most people still do not know what to do with the data. 

A wearable can tell someone they slept poorly. It cannot diagnose obstructive sleep apnea, prescribe treatment, adjust therapy, or monitor whether care is working over time. A lab test can show biological signals related to inflammation, metabolism, hormones, or cardiovascular risk. It usually cannot connect those signals to a sleep-specific clinical pathway. Traditional sleep clinics can diagnose and treat sleep disorders, but often only after symptoms become severe and after patients navigate a fragmented journey across physicians, sleep labs, device suppliers, insurers, and follow-up teams. 

This gap matters because sleep is not just a lifestyle habit. It is connected to metabolic health, cardiovascular risk, mental health, cognitive performance, safety, and long-term health. Obstructive sleep apnea is one of the clearest examples. The American Academy of Sleep Medicine estimates that nearly 30 million U.S. adults have obstructive sleep apnea, and about 80% remain undiagnosed. Newer estimates suggest the affected population may be significantly larger. 

The issue is not only diagnosis. It is continuity. Sleep care often fails after the test. Many patients are handed a CPAP device with limited onboarding, little mask support, and insufficient monitoring. When discomfort, leaks, pressure issues, or anxiety appear, patients are often left to solve the problem alone. In a category where long-term adherence determines outcomes, the traditional system is still built around disconnected transactions. 

The next phase of sleep health will require a new layer between passive measurement and fragmented care: a clinical action layer. 

That layer should connect sleep signals, biomarkers, symptoms, diagnosis, treatment, adherence, and outcomes in one continuous system. It should identify risk earlier, route patients into the right clinical pathway when needed, and keep monitoring whether treatment is working. In this model, sleep data is not just displayed. It is acted on. 

This is where the broader preventive health movement is heading. Biomarker platforms have shown that consumers are willing to understand their biology before they become sick. Wearables have shown that people want daily feedback on their bodies. Sleep is the natural next frontier because it is measured every night and affects nearly every major health system. 

The opportunity is not to build another dashboard. The opportunity is to close the loop: from signal to diagnosis, from diagnosis to treatment, and from treatment to measurable improvement. 

In healthcare, the companies that matter most are rarely the ones that only collect data. They are the ones that turn data into action. 

Mo Haouache is Co-Founder of Dumbo Health, a digital sleep care platform building the clinical action layer for sleep. Dumbo Health starts with obstructive sleep apnea and is expanding into sleep health monitoring through biomarkers, wearable data, diagnosis, treatment, and ongoing care. Mohamed previously founded Storefront and has spent his career building technology companies that simplify complex consumer experiences. Learn more at www.dumbo.health. 

The views reflected are the author's own and do not reflect the views of the FACC-NY.